Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131626) titled 'Effectiveness and Safety of Nanocrystalline Progesterone in Improving Appetite Loss and Nutritional Risk in the Elderly' on Sept. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University
Condition:
Anorexia in the elderly is accompanied by malnutrition.
Intervention:
Placebo group:Placebo (2.5mL PO, qd, for up to 12?weeks from treatment initiation)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target Sample Size: Placebo group:60;Nanocrystalform megestrol acetate group:60;
Countries of Re...